Evidence map›Paper›PMID 26262608›Full record

ReviewInternational journal of molecular sciences2015

Overview of Nrf2 as Therapeutic Target in Epilepsy.

Liliana Carmona-Aparicio, Claudia Pérez-Cruz, Cecilia Zavala-Tecuapetla, Leticia Granados-Rojas, Liliana Rivera-Espinosa, Hortencia Montesinos-Correa, Jacqueline Hernández-Damián, José Pedraza-Chaverri, Aristides Sampieri, Elvia Coballase-Urrutia and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Understanding the Molecular Basis of Miller-Dieker Syndrome.International journal of molecular sciences · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Liliana Carmona-AparicioLaboratory of Neurochemistry (Neurosciences), National Institute of Pediatrics, D.F. 04530, Mexico. lgranados_2000@yahoo.com.mx.
Claudia Pérez-CruzLaboratory of Neuroplasticity and Neurodegeneration, Cinvestav, D.F. 07360, Mexico. cau9@yahoo.com.
Cecilia Zavala-TecuapetlaLaboratory of Physiology of the Reticular Formation, National Institute of Neurology and Neurosurgery-MVS, D.F. 14269, Mexico. cztecua@yahoo.com.mx.
Leticia Granados-RojasLaboratory of Neurochemistry (Neurosciences), National Institute of Pediatrics, D.F. 04530, Mexico. lgranados_2000@yahoo.com.mx.
Liliana Rivera-EspinosaLaboratory of Pharmacology, National Institute of Pediatrics, D.F. 04530, Mexico. lili_rives@yahoo.com.
Hortencia Montesinos-CorreaService of Endocrinology, National Institute of Pediatrics, D.F. 04530, Mexico. hortenciamontesinoscorrea@yahoo.com.
Jacqueline Hernández-DamiánDepartment of Biology, Faculty of Chemistry, National Autonomous University of Mexico, D.F. 04150, Mexico. jdamian@email.ifc.unam.mx.
José Pedraza-ChaverriDepartment of Biology, Faculty of Chemistry, National Autonomous University of Mexico, D.F. 04150, Mexico.
Aristides SampieriDepartment of Comparative Biology, Faculty of Sciences, National Autonomous University of Mexico, D.F. 04150, Mexico. aris_sampieri@yahoo.com.mx.
Elvia Coballase-UrrutiaLaboratory of Neurochemistry (Neurosciences), National Institute of Pediatrics, D.F. 04530, Mexico. lgranados_2000@yahoo.com.mx.
Noemí Cárdenas-RodríguezLaboratory of Neurochemistry (Neurosciences), National Institute of Pediatrics, D.F. 04530, Mexico. lgranados_2000@yahoo.com.mx.
Universidad Nacional Autónoma de México · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInstituto Nacional de Neurología y Neurocirugía · MXNational Hospital of Pediatrics · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress is a biochemical state of imbalance in the production of reactive oxygen and nitrogen species and antioxidant defenses. It is involved in the physiopathology of degenerative and chronic neuronal disorders, such as epilepsy. Experimental evidence in humans and animals support the involvement of oxidative stress before and after seizures. In the past few years, research has increasingly focused on the molecular pathways of this process, such as that involving transcription factor nuclear factor E2-related factor 2 (Nrf2), which plays a central role in the regulation of antioxidant response elements (ARE) and modulates cellular redox status. The aim of this review is to present experimental evidence on the role of Nrf2 in this neurological disorder and to further determine the therapeutic impact of Nrf2 in epilepsy.

Indexed as

AnimalsEpilepsyHumansMolecular Targeted TherapyNF-E2-Related Factor 2Oxidative StressSignal TransductionNFE2L2 protein, humanNF-E2-Related Factor 2epilepsyNrf2stress oxidativetranscription factor nuclear

Identifiers

PMID26262608
PMCPMC4581249
OpenAlexW1925884394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.